The importance of knowing about Diabetes
Shakir Manzoor Khan
Stake holder engagement | Policy Advocate | A Jogii for Health & Community Well-being |Blogger #DEDOC VOICE | #IDF Blue circle voice
Diagnosing #diabetes is of utmost importance for several reasons:
In summary, the importance of diagnosing diabetes lies in facilitating early intervention, effective disease management, prevention of complications, promoting lifestyle modifications, providing patient education and support, and identifying high-risk individuals. Early diagnosis and appropriate management are crucial for improving health outcomes, reducing the burden of complications, and enhancing the overall quality of life for individuals with diabetes.
Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of beta cells, resulting in a loss of insulin production. Patients with T1D carry a substantial disease burden as well as substantial short-term and long-term risks associated with inadequate glycemic control.?
Currently, treatment mainly consists of insulin, which only treats the symptoms of T1D and not the root cause.?
Thus, disease-modifying agents such as anti-CD3 monoclonal antibodies (mAbs) that target the autoimmune destruction of beta cells in T1D would provide significant relief and health benefits for patients with T1D.
Anti-CD3 mAbs have shown significant benefits in both patients at high risk for T1D and those with recent-onset T1D.?
In high-risk populations, anti-CD3 mAbs delayed time to diagnosis, preserved C-peptide levels, and improved metabolic parameters. In recent-onset T1D, anti-CD3 mAbs preserved C-peptide levels and reduced insulin needs for extended periods.?
Anti-CD3 mAb therapy appears to be safe, with primarily transient and self-limiting adverse effects and no negative long-term effects. and this is about c-peptide , C-peptide helps?in the management of the two most prevalent forms of diabetes
领英推荐
Impaired beta-cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of insulin secretory capacity are useful to inform clinical practice, helping to classify types of diabetes, complication risk stratification and to guide treatment decisions. Because C-peptide secretion mirrors beta-cell function, it has emerged as a valuable clinical biomarker, mainly in autoimmune diabetes and especially in adult-onset diabetes.
?Nonetheless, the lack of robust evidence about the clinical utility of C-peptide measurement in type 2 diabetes, where insulin resistance is a major confounder, limits its use in such cases. Furthermore, problems remain in the standardization of the assay for C-peptide, raising concerns about comparability of measurements between different laboratories. To approach the heterogeneity and complexity of diabetes, reliable, simple and inexpensive clinical markers are required that can inform clinicians about probable pathophysiology and disease progression, and so enable personalization of management and therapy.
Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to the body's inability to properly utilize insulin or insulin resistance. Insulin is a hormone produced by the pancreas that regulates the uptake and utilization of glucose (sugar) from the bloodstream into the body's cells.
The exact cause of type 2 diabetes is not fully understood, but several factors contribute to its development. These include:
Diagnosing type 2 diabetes typically involves the following:
It's important to note that a diagnosis of type 2 diabetes is made by a healthcare professional based on a combination of symptoms, medical history, and test results. If you suspect you may have diabetes or are at risk, it's crucial to consult a healthcare provider for an accurate diagnosis and appropriate management.